nodes	percent_of_prediction	percent_of_DWPC	metapath
Nizatidine—ABCB1—Vismodegib—skin cancer	0.288	0.557	CbGbCtD
Nizatidine—ABCB1—Dactinomycin—skin cancer	0.152	0.292	CbGbCtD
Nizatidine—ABCB1—Docetaxel—skin cancer	0.0782	0.151	CbGbCtD
Nizatidine—Hepatic enzyme increased—Vismodegib—skin cancer	0.0136	0.0282	CcSEcCtD
Nizatidine—Tooth disorder—Imiquimod—skin cancer	0.0105	0.0217	CcSEcCtD
Nizatidine—Vasculitis—Vemurafenib—skin cancer	0.00814	0.0169	CcSEcCtD
Nizatidine—Gout—Imiquimod—skin cancer	0.00726	0.0151	CcSEcCtD
Nizatidine—Hepatic enzyme increased—Imiquimod—skin cancer	0.00717	0.0149	CcSEcCtD
Nizatidine—Tooth disorder—Temozolomide—skin cancer	0.00626	0.013	CcSEcCtD
Nizatidine—Back pain—Vismodegib—skin cancer	0.00544	0.0113	CcSEcCtD
Nizatidine—Nasal congestion—Imiquimod—skin cancer	0.0054	0.0112	CcSEcCtD
Nizatidine—Dermatitis exfoliative—Imiquimod—skin cancer	0.00522	0.0108	CcSEcCtD
Nizatidine—Eosinophilia—Vemurafenib—skin cancer	0.00494	0.0102	CcSEcCtD
Nizatidine—Liver injury—Temozolomide—skin cancer	0.00483	0.01	CcSEcCtD
Nizatidine—Myalgia—Vismodegib—skin cancer	0.00479	0.00994	CcSEcCtD
Nizatidine—Irritability—Imiquimod—skin cancer	0.0047	0.00975	CcSEcCtD
Nizatidine—Hepatic enzyme increased—Temozolomide—skin cancer	0.0043	0.00891	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00418	0.00868	CcSEcCtD
Nizatidine—Dyspepsia—Vismodegib—skin cancer	0.00404	0.00839	CcSEcCtD
Nizatidine—Decreased appetite—Vismodegib—skin cancer	0.00399	0.00828	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Vismodegib—skin cancer	0.00396	0.00823	CcSEcCtD
Nizatidine—Pain—Vismodegib—skin cancer	0.00393	0.00815	CcSEcCtD
Nizatidine—Constipation—Vismodegib—skin cancer	0.00393	0.00815	CcSEcCtD
Nizatidine—Erectile dysfunction—Imiquimod—skin cancer	0.00392	0.00813	CcSEcCtD
Nizatidine—Gastrointestinal pain—Vismodegib—skin cancer	0.00375	0.00779	CcSEcCtD
Nizatidine—Abdominal pain—Vismodegib—skin cancer	0.00363	0.00753	CcSEcCtD
Nizatidine—Sinusitis—Imiquimod—skin cancer	0.00356	0.00738	CcSEcCtD
Nizatidine—Rhinitis—Imiquimod—skin cancer	0.00341	0.00708	CcSEcCtD
Nizatidine—Pharyngitis—Imiquimod—skin cancer	0.00338	0.00701	CcSEcCtD
Nizatidine—Back pain—Vemurafenib—skin cancer	0.00336	0.00698	CcSEcCtD
Nizatidine—Asthenia—Vismodegib—skin cancer	0.00329	0.00684	CcSEcCtD
Nizatidine—Pruritus—Vismodegib—skin cancer	0.00325	0.00674	CcSEcCtD
Nizatidine—Nasal congestion—Temozolomide—skin cancer	0.00324	0.00672	CcSEcCtD
Nizatidine—Diarrhoea—Vismodegib—skin cancer	0.00314	0.00652	CcSEcCtD
Nizatidine—Dermatitis exfoliative—Temozolomide—skin cancer	0.00313	0.00649	CcSEcCtD
Nizatidine—Cough—Vemurafenib—skin cancer	0.00303	0.00629	CcSEcCtD
Nizatidine—Bronchospasm—Bleomycin—skin cancer	0.00297	0.00617	CcSEcCtD
Nizatidine—Myalgia—Vemurafenib—skin cancer	0.00296	0.00614	CcSEcCtD
Nizatidine—Vomiting—Vismodegib—skin cancer	0.00292	0.00606	CcSEcCtD
Nizatidine—Rash—Vismodegib—skin cancer	0.00289	0.00601	CcSEcCtD
Nizatidine—Dermatitis—Vismodegib—skin cancer	0.00289	0.006	CcSEcCtD
Nizatidine—Back pain—Imiquimod—skin cancer	0.00287	0.00595	CcSEcCtD
Nizatidine—Anaphylactic shock—Vemurafenib—skin cancer	0.00284	0.00589	CcSEcCtD
Nizatidine—Infection—Vemurafenib—skin cancer	0.00282	0.00585	CcSEcCtD
Nizatidine—Nausea—Vismodegib—skin cancer	0.00273	0.00566	CcSEcCtD
Nizatidine—Pneumonia—Bleomycin—skin cancer	0.00271	0.00562	CcSEcCtD
Nizatidine—Hepatocellular injury—Docetaxel—skin cancer	0.0027	0.00561	CcSEcCtD
Nizatidine—Irritability—Fluorouracil—skin cancer	0.00259	0.00538	CcSEcCtD
Nizatidine—Cough—Imiquimod—skin cancer	0.00259	0.00537	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00258	0.00536	CcSEcCtD
Nizatidine—Convulsion—Imiquimod—skin cancer	0.00257	0.00533	CcSEcCtD
Nizatidine—Pneumonia—Dactinomycin—skin cancer	0.00253	0.00525	CcSEcCtD
Nizatidine—Chest pain—Imiquimod—skin cancer	0.00252	0.00524	CcSEcCtD
Nizatidine—Myalgia—Imiquimod—skin cancer	0.00252	0.00524	CcSEcCtD
Nizatidine—Anxiety—Imiquimod—skin cancer	0.00251	0.00522	CcSEcCtD
Nizatidine—Dry mouth—Imiquimod—skin cancer	0.00247	0.00512	CcSEcCtD
Nizatidine—Decreased appetite—Vemurafenib—skin cancer	0.00247	0.00512	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00245	0.00508	CcSEcCtD
Nizatidine—Nasopharyngitis—Fluorouracil—skin cancer	0.00243	0.00504	CcSEcCtD
Nizatidine—Constipation—Vemurafenib—skin cancer	0.00243	0.00503	CcSEcCtD
Nizatidine—Infection—Imiquimod—skin cancer	0.0024	0.00499	CcSEcCtD
Nizatidine—Erectile dysfunction—Temozolomide—skin cancer	0.00235	0.00487	CcSEcCtD
Nizatidine—Hyperhidrosis—Imiquimod—skin cancer	0.00234	0.00485	CcSEcCtD
Nizatidine—Eosinophilia—Fluorouracil—skin cancer	0.00233	0.00483	CcSEcCtD
Nizatidine—Anorexia—Imiquimod—skin cancer	0.00231	0.00479	CcSEcCtD
Nizatidine—Pneumonia—Temozolomide—skin cancer	0.00229	0.00474	CcSEcCtD
Nizatidine—Hepatitis—Dactinomycin—skin cancer	0.00226	0.00468	CcSEcCtD
Nizatidine—Body temperature increased—Vemurafenib—skin cancer	0.00224	0.00465	CcSEcCtD
Nizatidine—Pharyngitis—Dactinomycin—skin cancer	0.00224	0.00465	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.0022	0.00457	CcSEcCtD
Nizatidine—Insomnia—Imiquimod—skin cancer	0.00219	0.00454	CcSEcCtD
Nizatidine—Somnolence—Imiquimod—skin cancer	0.00215	0.00446	CcSEcCtD
Nizatidine—Sinusitis—Temozolomide—skin cancer	0.00213	0.00443	CcSEcCtD
Nizatidine—Dyspepsia—Imiquimod—skin cancer	0.00213	0.00442	CcSEcCtD
Nizatidine—Pneumonia—Fluorouracil—skin cancer	0.00211	0.00437	CcSEcCtD
Nizatidine—Decreased appetite—Imiquimod—skin cancer	0.0021	0.00436	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Imiquimod—skin cancer	0.00209	0.00433	CcSEcCtD
Nizatidine—Pain—Imiquimod—skin cancer	0.00207	0.00429	CcSEcCtD
Nizatidine—Hepatitis—Temozolomide—skin cancer	0.00204	0.00423	CcSEcCtD
Nizatidine—Asthenia—Vemurafenib—skin cancer	0.00203	0.00422	CcSEcCtD
Nizatidine—Pharyngitis—Temozolomide—skin cancer	0.00202	0.0042	CcSEcCtD
Nizatidine—Pruritus—Vemurafenib—skin cancer	0.00201	0.00416	CcSEcCtD
Nizatidine—Feeling abnormal—Imiquimod—skin cancer	0.00199	0.00414	CcSEcCtD
Nizatidine—Gastrointestinal pain—Imiquimod—skin cancer	0.00198	0.00411	CcSEcCtD
Nizatidine—Sinusitis—Fluorouracil—skin cancer	0.00196	0.00408	CcSEcCtD
Nizatidine—Anaemia—Bleomycin—skin cancer	0.00195	0.00404	CcSEcCtD
Nizatidine—Diarrhoea—Vemurafenib—skin cancer	0.00194	0.00403	CcSEcCtD
Nizatidine—Urticaria—Imiquimod—skin cancer	0.00192	0.00399	CcSEcCtD
Nizatidine—Body temperature increased—Imiquimod—skin cancer	0.00191	0.00397	CcSEcCtD
Nizatidine—Abdominal pain—Imiquimod—skin cancer	0.00191	0.00397	CcSEcCtD
Nizatidine—Rhinitis—Fluorouracil—skin cancer	0.00188	0.00391	CcSEcCtD
Nizatidine—Dizziness—Vemurafenib—skin cancer	0.00188	0.00389	CcSEcCtD
Nizatidine—Pharyngitis—Fluorouracil—skin cancer	0.00187	0.00387	CcSEcCtD
Nizatidine—Cough—Bleomycin—skin cancer	0.00184	0.00381	CcSEcCtD
Nizatidine—Anaemia—Dactinomycin—skin cancer	0.00181	0.00377	CcSEcCtD
Nizatidine—Vomiting—Vemurafenib—skin cancer	0.0018	0.00374	CcSEcCtD
Nizatidine—Myalgia—Bleomycin—skin cancer	0.00179	0.00372	CcSEcCtD
Nizatidine—Chest pain—Bleomycin—skin cancer	0.00179	0.00372	CcSEcCtD
Nizatidine—Rash—Vemurafenib—skin cancer	0.00179	0.00371	CcSEcCtD
Nizatidine—Dermatitis—Vemurafenib—skin cancer	0.00179	0.00371	CcSEcCtD
Nizatidine—Headache—Vemurafenib—skin cancer	0.00178	0.00369	CcSEcCtD
Nizatidine—Nasopharyngitis—Docetaxel—skin cancer	0.00175	0.00364	CcSEcCtD
Nizatidine—Asthenia—Imiquimod—skin cancer	0.00174	0.0036	CcSEcCtD
Nizatidine—Confusional state—Bleomycin—skin cancer	0.00173	0.0036	CcSEcCtD
Nizatidine—Anaphylactic shock—Bleomycin—skin cancer	0.00172	0.00357	CcSEcCtD
Nizatidine—Back pain—Temozolomide—skin cancer	0.00172	0.00357	CcSEcCtD
Nizatidine—Pruritus—Imiquimod—skin cancer	0.00171	0.00355	CcSEcCtD
Nizatidine—Infection—Bleomycin—skin cancer	0.00171	0.00354	CcSEcCtD
Nizatidine—Nausea—Vemurafenib—skin cancer	0.00168	0.0035	CcSEcCtD
Nizatidine—Thrombocytopenia—Bleomycin—skin cancer	0.00168	0.00349	CcSEcCtD
Nizatidine—Myalgia—Dactinomycin—skin cancer	0.00167	0.00347	CcSEcCtD
Nizatidine—Bronchospasm—Docetaxel—skin cancer	0.00167	0.00346	CcSEcCtD
Nizatidine—Diarrhoea—Imiquimod—skin cancer	0.00165	0.00343	CcSEcCtD
Nizatidine—Anaemia—Temozolomide—skin cancer	0.00164	0.00341	CcSEcCtD
Nizatidine—Anorexia—Bleomycin—skin cancer	0.00164	0.0034	CcSEcCtD
Nizatidine—Dizziness—Imiquimod—skin cancer	0.0016	0.00332	CcSEcCtD
Nizatidine—Infection—Dactinomycin—skin cancer	0.00159	0.0033	CcSEcCtD
Nizatidine—Thrombocytopenia—Dactinomycin—skin cancer	0.00157	0.00326	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00157	0.00325	CcSEcCtD
Nizatidine—Cough—Temozolomide—skin cancer	0.00155	0.00322	CcSEcCtD
Nizatidine—Convulsion—Temozolomide—skin cancer	0.00154	0.00319	CcSEcCtD
Nizatidine—Vomiting—Imiquimod—skin cancer	0.00154	0.00319	CcSEcCtD
Nizatidine—Anorexia—Dactinomycin—skin cancer	0.00153	0.00317	CcSEcCtD
Nizatidine—Rash—Imiquimod—skin cancer	0.00152	0.00317	CcSEcCtD
Nizatidine—Dermatitis—Imiquimod—skin cancer	0.00152	0.00316	CcSEcCtD
Nizatidine—Pneumonia—Docetaxel—skin cancer	0.00152	0.00316	CcSEcCtD
Nizatidine—Headache—Imiquimod—skin cancer	0.00152	0.00314	CcSEcCtD
Nizatidine—Anaemia—Fluorouracil—skin cancer	0.00151	0.00314	CcSEcCtD
Nizatidine—Myalgia—Temozolomide—skin cancer	0.00151	0.00314	CcSEcCtD
Nizatidine—Anxiety—Temozolomide—skin cancer	0.00151	0.00313	CcSEcCtD
Nizatidine—Decreased appetite—Bleomycin—skin cancer	0.00149	0.0031	CcSEcCtD
Nizatidine—Dry mouth—Temozolomide—skin cancer	0.00148	0.00307	CcSEcCtD
Nizatidine—Jaundice—Docetaxel—skin cancer	0.00147	0.00306	CcSEcCtD
Nizatidine—Pain—Bleomycin—skin cancer	0.00147	0.00305	CcSEcCtD
Nizatidine—Confusional state—Temozolomide—skin cancer	0.00146	0.00303	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00146	0.00303	CcSEcCtD
Nizatidine—Anaphylactic shock—Temozolomide—skin cancer	0.00145	0.00301	CcSEcCtD
Nizatidine—Infection—Temozolomide—skin cancer	0.00144	0.00299	CcSEcCtD
Nizatidine—Nausea—Imiquimod—skin cancer	0.00144	0.00298	CcSEcCtD
Nizatidine—Thrombocytopenia—Temozolomide—skin cancer	0.00142	0.00295	CcSEcCtD
Nizatidine—Convulsion—Fluorouracil—skin cancer	0.00142	0.00294	CcSEcCtD
Nizatidine—Feeling abnormal—Bleomycin—skin cancer	0.00142	0.00294	CcSEcCtD
Nizatidine—Hyperhidrosis—Temozolomide—skin cancer	0.0014	0.00291	CcSEcCtD
Nizatidine—Chest pain—Fluorouracil—skin cancer	0.00139	0.00289	CcSEcCtD
Nizatidine—Myalgia—Fluorouracil—skin cancer	0.00139	0.00289	CcSEcCtD
Nizatidine—Decreased appetite—Dactinomycin—skin cancer	0.00139	0.00289	CcSEcCtD
Nizatidine—Anorexia—Temozolomide—skin cancer	0.00138	0.00287	CcSEcCtD
Nizatidine—Pain—Dactinomycin—skin cancer	0.00137	0.00284	CcSEcCtD
Nizatidine—Urticaria—Bleomycin—skin cancer	0.00137	0.00283	CcSEcCtD
Nizatidine—Rhinitis—Docetaxel—skin cancer	0.00136	0.00282	CcSEcCtD
Nizatidine—Body temperature increased—Bleomycin—skin cancer	0.00136	0.00282	CcSEcCtD
Nizatidine—Hepatitis—Docetaxel—skin cancer	0.00136	0.00282	CcSEcCtD
Nizatidine—Confusional state—Fluorouracil—skin cancer	0.00135	0.00279	CcSEcCtD
Nizatidine—Pharyngitis—Docetaxel—skin cancer	0.00135	0.00279	CcSEcCtD
Nizatidine—Anaphylactic shock—Fluorouracil—skin cancer	0.00134	0.00277	CcSEcCtD
Nizatidine—Infection—Fluorouracil—skin cancer	0.00133	0.00275	CcSEcCtD
Nizatidine—Feeling abnormal—Dactinomycin—skin cancer	0.00132	0.00274	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00132	0.00274	CcSEcCtD
Nizatidine—Insomnia—Temozolomide—skin cancer	0.00131	0.00272	CcSEcCtD
Nizatidine—Gastrointestinal pain—Dactinomycin—skin cancer	0.00131	0.00272	CcSEcCtD
Nizatidine—Thrombocytopenia—Fluorouracil—skin cancer	0.00131	0.00271	CcSEcCtD
Nizatidine—Somnolence—Temozolomide—skin cancer	0.00129	0.00267	CcSEcCtD
Nizatidine—Dyspepsia—Temozolomide—skin cancer	0.00128	0.00265	CcSEcCtD
Nizatidine—Anorexia—Fluorouracil—skin cancer	0.00127	0.00264	CcSEcCtD
Nizatidine—Body temperature increased—Dactinomycin—skin cancer	0.00127	0.00263	CcSEcCtD
Nizatidine—Abdominal pain—Dactinomycin—skin cancer	0.00127	0.00263	CcSEcCtD
Nizatidine—Decreased appetite—Temozolomide—skin cancer	0.00126	0.00262	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Temozolomide—skin cancer	0.00125	0.0026	CcSEcCtD
Nizatidine—Constipation—Temozolomide—skin cancer	0.00124	0.00257	CcSEcCtD
Nizatidine—Pain—Temozolomide—skin cancer	0.00124	0.00257	CcSEcCtD
Nizatidine—Asthenia—Bleomycin—skin cancer	0.00123	0.00256	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00122	0.00253	CcSEcCtD
Nizatidine—Pruritus—Bleomycin—skin cancer	0.00122	0.00252	CcSEcCtD
Nizatidine—Insomnia—Fluorouracil—skin cancer	0.00121	0.00251	CcSEcCtD
Nizatidine—Feeling abnormal—Temozolomide—skin cancer	0.00119	0.00248	CcSEcCtD
Nizatidine—Somnolence—Fluorouracil—skin cancer	0.00119	0.00246	CcSEcCtD
Nizatidine—Gastrointestinal pain—Temozolomide—skin cancer	0.00119	0.00246	CcSEcCtD
Nizatidine—Dyspepsia—Fluorouracil—skin cancer	0.00118	0.00244	CcSEcCtD
Nizatidine—Decreased appetite—Fluorouracil—skin cancer	0.00116	0.00241	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00115	0.00239	CcSEcCtD
Nizatidine—Urticaria—Temozolomide—skin cancer	0.00115	0.00239	CcSEcCtD
Nizatidine—Asthenia—Dactinomycin—skin cancer	0.00115	0.00239	CcSEcCtD
Nizatidine—Body temperature increased—Temozolomide—skin cancer	0.00115	0.00238	CcSEcCtD
Nizatidine—Abdominal pain—Temozolomide—skin cancer	0.00115	0.00238	CcSEcCtD
Nizatidine—Back pain—Docetaxel—skin cancer	0.00114	0.00237	CcSEcCtD
Nizatidine—Pain—Fluorouracil—skin cancer	0.00114	0.00237	CcSEcCtD
Nizatidine—Feeling abnormal—Fluorouracil—skin cancer	0.0011	0.00228	CcSEcCtD
Nizatidine—Diarrhoea—Dactinomycin—skin cancer	0.0011	0.00228	CcSEcCtD
Nizatidine—Vomiting—Bleomycin—skin cancer	0.00109	0.00227	CcSEcCtD
Nizatidine—Anaemia—Docetaxel—skin cancer	0.00109	0.00227	CcSEcCtD
Nizatidine—Rash—Bleomycin—skin cancer	0.00108	0.00225	CcSEcCtD
Nizatidine—Dermatitis—Bleomycin—skin cancer	0.00108	0.00225	CcSEcCtD
Nizatidine—Urticaria—Fluorouracil—skin cancer	0.00106	0.0022	CcSEcCtD
Nizatidine—Body temperature increased—Fluorouracil—skin cancer	0.00106	0.00219	CcSEcCtD
Nizatidine—Asthenia—Temozolomide—skin cancer	0.00104	0.00216	CcSEcCtD
Nizatidine—Cough—Docetaxel—skin cancer	0.00103	0.00214	CcSEcCtD
Nizatidine—Pruritus—Temozolomide—skin cancer	0.00103	0.00213	CcSEcCtD
Nizatidine—Convulsion—Docetaxel—skin cancer	0.00102	0.00212	CcSEcCtD
Nizatidine—Nausea—Bleomycin—skin cancer	0.00102	0.00212	CcSEcCtD
Nizatidine—Vomiting—Dactinomycin—skin cancer	0.00102	0.00211	CcSEcCtD
Nizatidine—Rash—Dactinomycin—skin cancer	0.00101	0.0021	CcSEcCtD
Nizatidine—Chest pain—Docetaxel—skin cancer	0.00101	0.00209	CcSEcCtD
Nizatidine—Myalgia—Docetaxel—skin cancer	0.00101	0.00209	CcSEcCtD
Nizatidine—Diarrhoea—Temozolomide—skin cancer	0.000992	0.00206	CcSEcCtD
Nizatidine—Dry mouth—Docetaxel—skin cancer	0.000983	0.00204	CcSEcCtD
Nizatidine—Confusional state—Docetaxel—skin cancer	0.000972	0.00202	CcSEcCtD
Nizatidine—Anaphylactic shock—Docetaxel—skin cancer	0.000964	0.002	CcSEcCtD
Nizatidine—Dizziness—Temozolomide—skin cancer	0.000958	0.00199	CcSEcCtD
Nizatidine—Infection—Docetaxel—skin cancer	0.000958	0.00199	CcSEcCtD
Nizatidine—Nausea—Dactinomycin—skin cancer	0.000952	0.00198	CcSEcCtD
Nizatidine—Pruritus—Fluorouracil—skin cancer	0.000945	0.00196	CcSEcCtD
Nizatidine—Thrombocytopenia—Docetaxel—skin cancer	0.000944	0.00196	CcSEcCtD
Nizatidine—Vomiting—Temozolomide—skin cancer	0.000922	0.00191	CcSEcCtD
Nizatidine—Anorexia—Docetaxel—skin cancer	0.000919	0.00191	CcSEcCtD
Nizatidine—Rash—Temozolomide—skin cancer	0.000914	0.0019	CcSEcCtD
Nizatidine—Diarrhoea—Fluorouracil—skin cancer	0.000914	0.0019	CcSEcCtD
Nizatidine—Dermatitis—Temozolomide—skin cancer	0.000913	0.0019	CcSEcCtD
Nizatidine—Headache—Temozolomide—skin cancer	0.000908	0.00188	CcSEcCtD
Nizatidine—Dizziness—Fluorouracil—skin cancer	0.000883	0.00183	CcSEcCtD
Nizatidine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000878	0.00182	CcSEcCtD
Nizatidine—Insomnia—Docetaxel—skin cancer	0.000872	0.00181	CcSEcCtD
Nizatidine—Nausea—Temozolomide—skin cancer	0.000861	0.00179	CcSEcCtD
Nizatidine—Somnolence—Docetaxel—skin cancer	0.000857	0.00178	CcSEcCtD
Nizatidine—Vomiting—Fluorouracil—skin cancer	0.000849	0.00176	CcSEcCtD
Nizatidine—Dyspepsia—Docetaxel—skin cancer	0.000848	0.00176	CcSEcCtD
Nizatidine—Rash—Fluorouracil—skin cancer	0.000842	0.00175	CcSEcCtD
Nizatidine—Dermatitis—Fluorouracil—skin cancer	0.000841	0.00175	CcSEcCtD
Nizatidine—Decreased appetite—Docetaxel—skin cancer	0.000838	0.00174	CcSEcCtD
Nizatidine—Headache—Fluorouracil—skin cancer	0.000837	0.00174	CcSEcCtD
Nizatidine—Gastrointestinal disorder—Docetaxel—skin cancer	0.000832	0.00173	CcSEcCtD
Nizatidine—Pain—Docetaxel—skin cancer	0.000824	0.00171	CcSEcCtD
Nizatidine—Constipation—Docetaxel—skin cancer	0.000824	0.00171	CcSEcCtD
Nizatidine—Feeling abnormal—Docetaxel—skin cancer	0.000794	0.00165	CcSEcCtD
Nizatidine—Nausea—Fluorouracil—skin cancer	0.000793	0.00165	CcSEcCtD
Nizatidine—Gastrointestinal pain—Docetaxel—skin cancer	0.000788	0.00164	CcSEcCtD
Nizatidine—Abdominal pain—Docetaxel—skin cancer	0.000762	0.00158	CcSEcCtD
Nizatidine—Body temperature increased—Docetaxel—skin cancer	0.000762	0.00158	CcSEcCtD
Nizatidine—Asthenia—Docetaxel—skin cancer	0.000692	0.00144	CcSEcCtD
Nizatidine—Pruritus—Docetaxel—skin cancer	0.000682	0.00142	CcSEcCtD
Nizatidine—Diarrhoea—Docetaxel—skin cancer	0.000659	0.00137	CcSEcCtD
Nizatidine—Dizziness—Docetaxel—skin cancer	0.000637	0.00132	CcSEcCtD
Nizatidine—Vomiting—Docetaxel—skin cancer	0.000613	0.00127	CcSEcCtD
Nizatidine—Rash—Docetaxel—skin cancer	0.000608	0.00126	CcSEcCtD
Nizatidine—Dermatitis—Docetaxel—skin cancer	0.000607	0.00126	CcSEcCtD
Nizatidine—Headache—Docetaxel—skin cancer	0.000604	0.00125	CcSEcCtD
Nizatidine—Nausea—Docetaxel—skin cancer	0.000573	0.00119	CcSEcCtD
